Ms. Bhattacharya will cover the development and application of Nanoscope's Multi-Characteristic Opsin (MCO) platform towards mutation-agnostic, restorative treatment of multiple orphan diseases ...
As such, there is a need for advanced integrative neuroinformatics approaches, harnessing techniques in data science and machine learning/artificial intelligence, so that precision prognostication and ...
The volatility ratio for the week is 8.22%, and the volatility levels for the last 30 days are 10.48% for Fate Therapeutics Inc The simple moving average for the past 20 days is 1.47% for FATE’s stock ...
Orexigen Therapeutics (OREX) shares are rising after the company sold $60 million worth of common stock to Baupost Group. Orexigen Therapeutics (OREX) shares are rising after the company sold $60 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results